Skip to content

BBNX BBNX Net margin

Net margin at other companies

Insulet logo
InsuletPODD
10.4%-7.9pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-9.2%-3.1pp
Medtronic logo
MedtronicMDT
13.2%-0.7pp
AdaptHealth logo
AdaptHealthAHCO
-2.4%-5.1pp
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
47.9%+6.5pp

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Calculated from BBNX’s reported figures.

Based on trailing twelve months.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's net margin?
BBNX (BBNX) reported net margin of -60.3% in Q1 2026.
How has BBNX's net margin changed year-over-year?
BBNX's net margin increased by 40.7% year-over-year, from -101.6% to -60.3%.
What is the long-term trend for BBNX's net margin?
Over 2 years (2023 to 2025), BBNX's net margin has grown at a -55.4% compound annual growth rate (CAGR), from -367.6% to -73%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.